Korea’s LG Life Sciences And Japan’s Mochida Cut Biosimilar Deal
This article was originally published in PharmAsia News
Executive Summary
LG Life Sciences ramps up its biosimilars development in Korea and Japan through deal with Japan’s Mochida that covers development and commercialization activities.